Intelligent Bio Solutions to Participate in Noble Capital Markets’ 21st Annual Emerging Growth Equity Conference on December 2-3, 2025
Intelligent Bio Solutions (NASDAQ: INBS) announced management will participate in Noble Capital Markets’ 21st Annual Emerging Growth Equity Conference on December 2–3, 2025 in Boca Raton, Florida.
The company will present on Wednesday, December 3, 2025 at 11:00 a.m. ET in Presentation Room 2 at Florida Atlantic University. A webcast recording will be available the following day on the company investor relations site, Noble’s website, and Channelchek for 90 days.
Investors may register with discount code INBSNOBLECON. To schedule one-on-one meetings or request more information, contact a Noble Capital Markets representative or email KCSA Strategic Communications at INBS@ksca.com.
Intelligent Bio Solutions (NASDAQ: INBS) ha annunciato che la direzione parteciperà alla 21a Annual Emerging Growth Equity Conference di Noble Capital Markets il 2–3 dicembre 2025 a Boca Raton, Florida.
L'azienda terrà la presentazione mercoledì 3 dicembre 2025 alle 11:00 a.m. ET nella Presentation Room 2 presso la Florida Atlantic University. Una registrazione webcast sarà disponibile il giorno seguente sul sito di relazioni con gli investitori dell'azienda, sul sito di Noble e su Channelchek per 90 giorni.
Gli investitori possono registrarsi utilizzando il codice sconto INBSNOBLECON. Per programmare incontri individuali o richiedere ulteriori informazioni, contattare un rappresentante di Noble Capital Markets oppure inviare un'email a KCSA Strategic Communications all'indirizzo INBS@ksca.com.
Intelligent Bio Solutions (NASDAQ: INBS) anunció que la dirección participará en la 21ª Conferencia Anual de Growth Equity de Noble Capital Markets los días 2 y 3 de diciembre de 2025 en Boca Raton, Florida.
La compañía presentará el miércoles 3 de diciembre de 2025 a las 11:00 a.m. ET en la Sala de Presentaciones 2 de la Florida Atlantic University. Una grabación de webcast estará disponible al día siguiente en el sitio de relaciones con inversores de la empresa, en el sitio de Noble y en Channelchek por 90 días.
Los inversores pueden registrarse con el código de descuento INBSNOBLECON. Para programar reuniones One-on-One o solicitar más información, contacte a un representante de Noble Capital Markets o envíe un correo a KCSA Strategic Communications a INBS@ksca.com.
Intelligent Bio Solutions (NASDAQ: INBS)는 Noble Capital Markets의 제21차 연례 성장주 부문 컨퍼런스에 경영진이 참석할 예정이라고 발표했습니다. 행사는 2025년 12월 2-3일, 플로리다 주 보카 라트론에서 열립니다.
회사는 2025년 12월 3일 수요일 오전 11:00(동부 표준시)에 Florida Atlantic University의 Presentation Room 2에서 발표합니다. 다음 날 회사의 투자자 관계 사이트, Noble의 웹사이트, Channelchek에서 90일간 웹캐스트 녹화본을 이용할 수 있습니다.
투자자는 할인 코드 INBSNOBLECON으로 등록할 수 있습니다. 일대일 미팅을 예약하거나 추가 정보를 요청하려면 Noble Capital Markets의 담당자에게 연락하거나 INBS@ksca.com으로 KCSA Strategic Communications에 이메일을 보내주십시오.
Intelligent Bio Solutions (NASDAQ : INBS) a annoncé que la direction participera au 21e Annual Emerging Growth Equity Conference de Noble Capital Markets les 2 et 3 décembre 2025 à Boca Raton, Floride.
L'entreprise présentera le mercredi 3 décembre 2025 à 11h00 HE dans la salle de présentation 2 à la Florida Atlantic University. Un enregistrement webcast sera disponible le lendemain sur le site des relations investisseurs de l'entreprise, sur le site de Noble et Channelchek pendant 90 jours.
Les investisseurs peuvent s'inscrire avec le code de réduction INBSNOBLECON. Pour programmer des réunions individuelles ou demander plus d'informations, contactez un représentant de Noble Capital Markets ou envoyez un e-mail à KCSA Strategic Communications à l'adresse INBS@ksca.com.
Intelligent Bio Solutions (NASDAQ: INBS) gab bekannt, dass das Management am Noble Capital Markets’ 21st Annual Emerging Growth Equity Conference teilnehmen wird, vom 2.–3. Dezember 2025 in Boca Raton, Florida.
Das Unternehmen wird Mittwoch, der 3. Dezember 2025 um 11:00 Uhr ET in Presentation Room 2 an der Florida Atlantic University präsentieren. Eine Webcast-Aufzeichnung wird am folgenden Tag auf der Investor-Relations-Website des Unternehmens, auf Nobles Website und Channelchek für 90 Tage verfügbar sein.
Investoren können sich mit dem Rabattcode INBSNOBLECON registrieren. Um One-on-One-Meetings zu planen oder weitere Informationen zu erhalten, wenden Sie sich an einen Vertreter von Noble Capital Markets oder senden Sie eine E-Mail an KCSA Strategic Communications an die Adresse INBS@ksca.com.
Intelligent Bio Solutions (ناسداك: INBS) أعلنت أن الإدارة ستشارك في Noble Capital Markets المؤتمر السنوي الحادي والعشرين لأسهم النمو Emerging Growth Equity Conference في 2-3 ديسمبر 2025 في بوكا راتون، فلوريدا.
ستقدم الشركة الأربعاء 3 ديسمبر 2025 الساعة 11:00 صباحاً بتوقيت شرق الولايات المتحدة في غرفة العرض 2 بجامعة Florida Atlantic University. ستكون هناك تسجيلات بث ويب متاحة في اليوم التالي على موقع علاقات المستثمرين للشركة، وعلى موقع Noble وعلى Channelchek لمدة 90 يوماً.
يمكن للمستثمرين التسجيل باستخدام رمز الخصم INBSNOBLECON. لإعداد لقاءات فردية واحد-إلى-واحد أو لطلب مزيد من المعلومات، يرجى التواصل مع ممثل Noble Capital Markets أو إرسال بريد إلكتروني إلى KCSA Strategic Communications على العنوان INBS@ksca.com.
- None.
- None.
NEW YORK, Nov. 20, 2025 (GLOBE NEWSWIRE) -- Intelligent Bio Solutions Inc. (Nasdaq: INBS) ("INBS" or the "Company"), a medical technology company delivering intelligent, rapid, non-invasive testing solutions, today announced that its management team will participate in Noble Capital Markets’ 21st Annual Emerging Growth Equity Conference, taking place over December 2-3, 2025, in Boca Raton, Florida.
Conference Details
Date: December 2–3, 2025
Location: Florida Atlantic University, Boca Raton, FL
Presentation Date and Time: Wednesday, December 3, 2025, 11:00 a.m. Eastern Time
Presentation Location: Presentation Room 2
A webcast recording of INBS’s presentation will be available the following day on INBS’s investor relations website, as well as Noble’s website and on Channelchek, for 90 days after the event.
Interested investors can register to attend here using the discount code INBSNOBLECON.
For more information about the conference, or to schedule a one-on-one meeting with the INBS management team, please contact your Noble Capital Markets representative or email KCSA Strategic Communications at INBS@ksca.com.
About Intelligent Bio Solutions Inc.
Intelligent Bio Solutions Inc. (NASDAQ: INBS) is a medical technology company delivering intelligent, rapid, non-invasive testing solutions. The Company believes that its Intelligent Fingerprinting Drug Screening System will revolutionize portable testing through fingerprint sweat analysis, which has the potential for broader applications in additional fields. Designed as a hygienic and cost-effective system, the test screens for the recent use of drugs commonly found in the workplace, including opiates, cocaine, methamphetamine, and cannabis. With sample collection in seconds and results in under ten minutes, this technology would be a valuable tool for employers in safety-critical industries. The Company’s current customer segments outside the U.S. include construction, manufacturing and engineering, transport and logistics firms, mining, drug treatment organizations, and coroners.
For more information, visit https://ibs.inc/
Company Contact
Intelligent Bio Solutions Inc.
info@ibs.inc
LinkedIn | Twitter
Investor & Media Contact
Valter Pinto, Managing Director
KCSA Strategic Communications
PH: (212) 896-1254
INBS@kcsa.com